Capital World Investors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.27B | Sell |
6,646,316
-4,357,498
| -40% | -$2.36B | 0.45% | 58 |
|
|
2025
Q4 | $6.38B | Buy |
11,003,814
+718,669
| +7% | +$406M | 0.87% | 27 |
|
|
2025
Q3 | $4.99B | Buy |
10,285,145
+706,572
| +7% | +$329M | 0.68% | 37 |
|
|
2025
Q2 | $3.88B | Sell |
9,578,573
-1,482,827
| -13% | -$620M | 0.56% | 47 |
|
|
2025
Q1 | $5.5B | Buy |
11,061,400
+1,631,280
| +17% | +$883M | 0.89% | 20 |
|
|
2024
Q4 | $4.91B | Buy |
9,430,120
+104,343
| +1% | +$57.4M | 0.74% | 29 |
|
|
2024
Q3 | $5.77B | Sell |
9,325,777
-192,659
| -2% | -$114M | 0.89% | 23 |
|
|
2024
Q2 | $5.26B | Sell |
9,518,436
-3,975,416
| -29% | -$2.28B | 0.86% | 23 |
|
|
2024
Q1 | $7.84B | Buy |
13,493,852
+1,231,059
| +10% | +$691M | 1.3% | 12 |
|
|
2023
Q4 | $6.51B | Sell |
12,262,793
-492,214
| -4% | -$238M | 1.16% | 13 |
|
|
2023
Q3 | $6.46B | Sell |
12,755,007
-121,091
| -0.9% | -$64.5M | 1.28% | 11 |
|
|
2023
Q2 | $6.72B | Sell |
12,876,098
-48,366
| -0.4% | -$26.1M | 1.29% | 13 |
|
|
2023
Q1 | $7.45B | Sell |
12,924,464
-620,777
| -5% | -$350M | 1.54% | 11 |
|
|
2022
Q4 | $7.46B | Buy |
13,545,241
+57,180
| +0.4% | +$30.3M | 1.59% | 9 |
|
|
2022
Q3 | $6.84B | Sell |
13,488,061
-501,558
| -4% | -$281M | 1.54% | 9 |
|
|
2022
Q2 | $7.6B | Sell |
13,989,619
-177,932
| -1% | -$97.9M | 1.61% | 9 |
|
|
2022
Q1 | $8.37B | Sell |
14,167,551
-682,179
| -5% | -$392M | 1.44% | 9 |
|
|
2021
Q4 | $9.91B | Sell |
14,849,730
-37,056
| -0.2% | -$23.1M | 1.57% | 9 |
|
|
2021
Q3 | $8.51B | Buy |
14,886,786
+114,582
| +0.8% | +$62.9M | 1.45% | 10 |
|
|
2021
Q2 | $7.45B | Sell |
14,772,204
-1,966,990
| -12% | -$928M | 1.27% | 12 |
|
|
2021
Q1 | $7.64B | Buy |
16,739,194
+757,674
| +5% | +$362M | 1.41% | 10 |
|
|
2020
Q4 | $7.44B | Sell |
15,981,520
-41,513
| -0.3% | -$19.5M | 1.43% | 10 |
|
|
2020
Q3 | $7.07B | Sell |
16,023,033
-548,434
| -3% | -$227M | 1.55% | 10 |
|
|
2020
Q2 | $6B | Sell |
16,571,467
-253,259
| -2% | -$84.9M | 1.45% | 12 |
|
|
2020
Q1 | $4.77B | Buy |
16,824,726
+1,242,140
| +8% | +$392M | 1.38% | 14 |
|
|
2019
Q4 | $5.06B | Sell |
15,582,586
-39,392
| -0.3% | -$11.9M | 1.13% | 16 |
|
|
2019
Q3 | $4.55B | Buy |
15,621,978
+8,880
| +0.1% | +$2.54M | 1.1% | 16 |
|
|
2019
Q2 | $4.59B | Buy |
15,613,098
+76,074
| +0.5% | +$21M | 1.08% | 18 |
|
|
2019
Q1 | $4.25B | Buy |
15,537,024
+547,242
| +4% | +$136M | 1.03% | 22 |
|
|
2018
Q4 | $3.35B | Sell |
14,989,782
-422,460
| -3% | -$99.1M | 0.91% | 27 |
|
|
2018
Q3 | $3.76B | Buy |
15,412,242
+2,482,783
| +19% | +$571M | 0.92% | 26 |
|
|
2018
Q2 | $2.68B | Buy |
12,929,459
+317,680
| +3% | +$67.4M | 0.57% | 48 |
|
|
2018
Q1 | $2.6B | Sell |
12,611,779
-277,943
| -2% | -$58.3M | 0.59% | 50 |
|
|
2017
Q4 | $2.45B | Buy |
12,889,722
+10,844
| +0.1% | +$2.08M | 0.53% | 50 |
|
|
2017
Q3 | $2.44B | Buy |
12,878,878
+1,119,144
| +10% | +$203M | 0.55% | 51 |
|
|
2017
Q2 | $2.05B | Buy |
11,759,734
+671,637
| +6% | +$113M | 0.48% | 57 |
|
|
2017
Q1 | $1.7B | Buy |
11,088,097
+1,266,545
| +13% | +$194M | 0.41% | 66 |
|
|
2016
Q4 | $1.39B | Sell |
9,821,552
-1,187,459
| -11% | -$175M | 0.35% | 75 |
|
|
2016
Q3 | $1.75B | Buy |
11,009,011
+4,485
| +0% | +$691K | 0.46% | 55 |
|
|
2016
Q2 | $1.63B | Buy |
11,004,526
+872
| +0% | +$129K | 0.44% | 57 |
|
|
2016
Q1 | $1.56B | Sell |
11,003,654
-354,926
| -3% | -$47.6M | 0.43% | 61 |
|
|
2015
Q4 | $1.61B | Buy |
11,358,580
+594,558
| +6% | +$79.3M | 0.45% | 56 |
|
|
2015
Q3 | $1.32B | Buy |
10,764,022
+938,396
| +10% | +$122M | 0.39% | 66 |
|
|
2015
Q2 | $1.27B | Buy |
9,825,626
+50,626
| +0.5% | +$6.6M | 0.35% | 76 |
|
|
2015
Q1 | $1.31B | Buy |
9,775,000
+2,517,000
| +35% | +$324M | 0.35% | 71 |
|
|
2014
Q4 | $909M | Buy |
7,258,000
+3,230,000
| +80% | +$393M | 0.25% | 105 |
|
|
2014
Q3 | $490M | Buy |
4,028,000
+996,000
| +33% | +$121M | 0.14% | 152 |
|
|
2014
Q2 | $358M | Buy |
3,032,000
+1,340,000
| +79% | +$158M | 0.1% | 190 |
|
|
2014
Q1 | $203M | Buy |
1,692,000
+642,000
| +61% | +$76.3M | 0.06% | 232 |
|
|
2013
Q4 | $117M | Hold |
1,050,000
| – | – | 0.03% | 284 |
|
|
2013
Q3 | $96.8M | Buy |
+1,050,000
| New | +$95M | 0.03% | 299 |
|
Other funds holding TMO
VCM
VPM
Capital World Investors's TMO Position: Q1 2026 in Review
Capital World Investors reduced its Thermo Fisher Scientific (TMO) stake by 40% in Q1 2026, selling an estimated $2.36B and leaving 6,646,316 shares worth $3.27B. The position accounts for 0.45% of the portfolio, ranked #58.
Capital World Investors first reported a position in TMO in Q3 2013 and has held it in 51 quarters since. The position peaked at $9.91B in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Capital World Investors held 6,646,316 shares of Thermo Fisher Scientific worth $3.27B as of Q1 2026.
- Capital World Investors sold 4,357,498 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.36B.
- Thermo Fisher Scientific made up 0.45% of Capital World Investors's portfolio in Q1 2026, its #58 holding.
- Capital World Investors first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 51 quarters since.
- Capital World Investors's Thermo Fisher Scientific position peaked at $9.91B in Q4 2021.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.